comparemela.com

Latest Breaking News On - ப்ரேசெனிுச் மருத்துவ பராமரிப்பு சிறுநீரகம் பார்மா - Page 1 : comparemela.com

ChemoCentryx, inc (CCXI) Q2 2021 Earnings Call Transcript

ChemoCentryx, inc (CCXI) Q2 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

OPKO Health Reports Transfer of Licensed Rights to

OPKO Health, Inc. (NASDAQ: OPK) today announced a transfer of the licensed rights to RAYALDEE ® in Japan from Japan Tobacco Inc. (JT) to Vifor Fresenius Medical Care Renal Pharma (VFMCRP). On May 17, 2021, JT notified OPKO of its decision to terminate the exclusive agreement with OPKO’s subsidiary, EirGen Pharma, Ltd., for the development and commercialization of RAYALDEE ® in Japan based on a comprehensive review of its development pipeline. Concurrently with the termination of JT’s rights, EirGen and VFMCRP have agreed to transfer the rights to RAYALDEE ® in Japan to VFMCRP by including Japan into the existing exclusive agreement between the two companies, executed on May 9, 2016, for the development and commercialization of RAYALDEE

How the Pandemic Is Shaping Patent Trials in District Courts | Troutman Pepper

To embed, copy and paste the code into your website or blog: This article explores the effect of the pandemic on patent trials. Early in the COVID-19 pandemic, rapidly shifting conditions, state and federal guidance, and many unknowns forced federal district courts to adapt their procedures. Courts faced the task of balancing the safety all involved in the case, including court staff, witnesses and lawyers, with concerns over fairness and access to justice. COVID-19 Procedures by Jurisdiction District courts with significant patent dockets, such as the U.S. District Courts for the District of Delaware, Northern District of California, Eastern District of Texas and Western District of Texas, all issued COVID-19 governing procedures that followed three basic steps.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.